apaflurane has been researched along with Chronic Illness in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eid, N; Morton, R | 1 |
| Duerden, M; Haughney, J; Moseley, C; Nicholls, C; Price, D | 1 |
| Ayres, JG; Millar, AB; Sykes, AP | 1 |
3 trial(s) available for apaflurane and Chronic Illness
| Article | Year |
|---|---|
Lung function changes in asthmatic children treated with HFA-BDP.
Topics: Aerosol Propellants; Anti-Asthmatic Agents; Asthma; Beclomethasone; Child; Child, Preschool; Chronic Disease; Female; Humans; Hydrocarbons, Fluorinated; Lung; Male; Respiratory Function Tests; Retrospective Studies | 2011 |
The cost effectiveness of chlorofluorocarbon-free beclomethasone dipropionate in the treatment of chronic asthma: a cost model based on a 1-year pragmatic, randomised clinical study.
Topics: Asthma; Beclomethasone; Chlorofluorocarbons; Chronic Disease; Cost-Benefit Analysis; Humans; Hydrocarbons, Fluorinated; Prospective Studies; Quality of Life; Treatment Outcome | 2002 |
Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosol Propellants; Aged; Androstadienes; Anti-Asthmatic Agents; Asthma; Chlorofluorocarbons; Chronic Disease; Cross-Over Studies; Double-Blind Method; Female; Fluticasone; Forced Expiratory Volume; Humans; Hydrocarbons, Fluorinated; Hydrocortisone; Male; Middle Aged; Peak Expiratory Flow Rate; Therapeutic Equivalency; Treatment Outcome | 2000 |